Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$879M |
| 2 |
Bank of America
BAC
|
+$352M |
| 3 |
Intel
INTC
|
+$243M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$232M |
| 5 |
AB InBev
BUD
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.82B |
| 2 |
Amazon
AMZN
|
+$884M |
| 3 |
Air Products & Chemicals
APD
|
+$219M |
| 4 |
Mondelez International
MDLZ
|
+$198M |
| 5 |
WFT
Weatherford International plc
WFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.22% |
| 2 | Technology | 1.15% |
| 3 | Consumer Discretionary | 1.1% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $322M | 0.16% |
830,400
+216,200
| +35% | +$80.1M |
|
|
102
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $312M | 0.16% |
806,300
+189,600
| +31% | +$70.3M |
|
103
CALL
Goldman Sachs
GS
$303B
| $310M | 0.16% |
1,351,100
-1,572,300
| -54% | -$380M |
|
|
VXX
104
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $307M | 0.16% |
4,866,625
-221,150
| -4% | -$16.4M |
|
105
CALL
Marathon Petroleum
MPC
$101B
| $299M | 0.15% |
5,922,700
-605,400
| -9% | -$30.1M |
|
106
PUT
Pfizer
PFE
$160B
| $294M | 0.15% |
9,044,585
-1,233,812
| -12% | -$38.9M |
|
|
107
AB InBev
BUD
$155B
| $293M | 0.15% |
2,668,144
+1,752,352
| +191% | +$188M |
|
|
108
VanEck Gold Miners ETF
GDX
$31.8B
| $293M | 0.15% |
12,825,458
+9,969,209
| +349% | +$232M |
|
|
PX
109
CALL
DELISTED
Praxair Inc
PX
| $290M | 0.15% |
2,444,600
+2,237,300
| +1,079% | +$263M |
|
110
PUT
GE Aerospace
GE
$361B
| $290M | 0.15% |
2,029,072
+43,631
| +2% | +$6.32M |
|
111
NVIDIA
NVDA
$5.2T
| $282M | 0.14% |
103,651,960
+67,862,600
| +190% | +$181M |
|
112
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
| $280M | 0.14% |
7,702,800
+7,111,600
| +1,203% | +$247M |
|
113
PUT
Chevron
CVX
$403B
| $279M | 0.14% |
2,596,800
-1,114,000
| -30% | -$125M |
|
114
CALL
American Airlines Group
AAL
$9.15B
| $277M | 0.14% |
6,539,700
-2,769,900
| -30% | -$125M |
|
115
PUT
Union Pacific
UNP
$183B
| $276M | 0.14% |
2,604,100
+288,800
| +12% | +$30.8M |
|
116
CALL
Walmart Inc
WMT
$825B
| $275M | 0.14% |
11,427,900
+4,842,600
| +74% | +$111M |
|
117
CALL
Home Depot
HD
$335B
| $273M | 0.14% |
1,862,500
+290,000
| +18% | +$41.1M |
|
118
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| $269M | 0.14% |
6,938,000
+475,500
| +7% | +$17.9M |
|
119
CALL
Amgen
AMGN
$238B
| $269M | 0.14% |
1,639,100
-618,100
| -27% | -$103M |
|
120
Berkshire Hathaway Class B
BRK.B
$1.06T
| $269M | 0.14% |
1,612,182
-270,996
| -14% | -$45.3M |
|
|
121
Intel
INTC
$476B
| $267M | 0.14% |
7,414,432
+6,715,868
| +961% | +$243M |
|
122
PUT
Baidu
BIDU
$31.6B
| $266M | 0.13% |
1,542,300
+34,100
| +2% | +$6M |
|
|
123
CALL
Intel
INTC
$476B
| $263M | 0.13% |
7,301,000
-590,600
| -7% | -$21.4M |
|
|
124
CALL
Pfizer
PFE
$160B
| $263M | 0.13% |
8,094,298
+1,200,295
| +17% | +$37.8M |
|
125
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$268M
| $262M | 0.13% |
324
+269
| +489% | +$308M |
|
Similar funds
Jeff Yass's Q1 2017 Portfolio in Review
As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass withdrew a net $14.4B in Q1 2017, closing 2,170 positions and reducing 3,726 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.
- Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
- Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
- Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
- Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
- Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
- Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.